ICRM
TMO icon

Insight Capital Research & Management’s Thermo Fisher Scientific TMO Stock Holding History

Insight Capital Research & Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,471
Closed -$1.83M – 133
2017
Q2 		$1.83M Buy
+10,471
New +$1.76M 1.07% 40
2016
Q3 		– Sell
-17,851
Closed -$2.64M – 126
2016
Q2 		$2.64M Buy
+17,851
New +$2.63M 0.92% 58

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Insight Capital Research & Management's TMO Position: Q3 2017 in Review

Insight Capital Research & Management sold out of Thermo Fisher Scientific (TMO) in Q3 2017, closing a stake of 10,471 shares — an estimated $1.83M sold.

Insight Capital Research & Management first reported a position in TMO in Q2 2016 and held it in 2 quarters. The position peaked at $2.64M in Q2 2016. 1,162 funds tracked by Wall St. Rank hold TMO as of Q3 2017.

  • Insight Capital Research & Management reported no remaining Thermo Fisher Scientific position as of Q3 2017 after selling out during the quarter.
  • Insight Capital Research & Management sold 10,471 Thermo Fisher Scientific shares in Q3 2017, an estimated $1.83M.
  • Insight Capital Research & Management first reported a position in Thermo Fisher Scientific in Q2 2016 and held it in 2 quarters.
  • Insight Capital Research & Management's Thermo Fisher Scientific position peaked at $2.64M in Q2 2016.
  • 1,162 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2017.

Based on Insight Capital Research & Management's 13F filing for Q3 2017, filed 15 Nov 2017.